Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyanokit for vasopressor refractory hypotension after cardiopulmonary bypass
NCT03735316Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxocobalamin in vasoplegic syndrome (VPS), sponsored by Mayo Clinic. Started Apr 2019; status: terminated.
02
Drugs
hydroxocobalamin
03
Conditions
vasoplegic syndrome (VPS)
Beyond the preview
Go deeper on NCT03735316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03735316.